Overview
Gavin Dunn is a Neurosurgery provider in Boston, Massachusetts. Dr. Dunn is rated as a Distinguished provider by MediFind in the treatment of Primitive Neuroectodermal Tumor (PNET). His top areas of expertise are Astrocytoma, Glioblastoma, Glioma, Awake Craniotomy, and Gamma Knife Radiosurgery. Dr. Dunn is currently accepting new patients.
His clinical research consists of co-authoring 128 peer reviewed articles and participating in 15 clinical trials. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MEDICAID
- STATE MEDICAID
Locations
55 Fruit St, Boston, MA 02114
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
15 Clinical Trials
MGH Brain Tumor Center
Dr. Brian Nahed is a neurosurgeon specializing in Brain Tumors (Glioblastoma, Low Grade Gliomas, Meningiomas, Metastatic Brain Tumors) and Brain Mapping / Intraoperative Imaging. He is Director of Neurosurgery Residency Program at MGH and Harvard Medical School and Associate Professor of Neurosurgery.Patient appointments: 617-724-5805. (Appointments / Second Opinions within 24 hrs.) Visit my web page.Dr. Nahed specializes in brain tumors of the eloquent cortex (language and motor areas of the brain) which require awake surgery, language and motor mapping, and subcortical stimulation. Dr. Nahed specializes in intraoperative technology and minimally invasive procedures to treat brain tumors aggressively and safely.Born in New York, Dr. Nahed attended UCLA where he majored in Neuroscience, graduating Phi Beta Kappa and with the department's Highest Honors. He attended the Yale School of Medicine where he was awarded the Doris Duke Clinical Research Fellowship and graduated with honors. Dr. Nahed completed his neurosurgery residency at the Massachusetts General Hospital; where Dr. Nahed completed a postdoctoral fellowship with Drs. Daniel Haber and Shyamala Maheswaran in the MGH Cancer Center.Dr. Brian Nahed was recruited to the MGH Department of Neurosurgery, MGH Brain Tumor Center, and Harvard Medical School in 2011. Dr. Brian Nahed's research focuses on developing the first blood based test to diagnose and monitor brain tumors. In collaboration with Drs. Haber, Maheswaran, and Stott, Dr. Nahed published the first evidence of circulating tumor cells in the blood of patients with glioblastoma. Drs Nahed and Stott run an NIH funded laboratory developing the first blood test for patients with brain tumors.As the Director of the MGH Neurosurgery Residency Program, he has led neurosurgical education. He serves on the Executive Committee of the Congress of Neurological Surgeons and the CNS/AANS Executive Committee For Brain Tumors. He is Co-Chair of the CNS Leadership Institute. He is an active member of the American Association of Neurological Surgeons and Council State Neurological Societies. Dr. Nahed serves as the lead neurotrauma consultant for the National Football League (NFL). Dr. Nahed is rated as an Elite provider by MediFind in the treatment of Primitive Neuroectodermal Tumor (PNET). His top areas of expertise are Astrocytoma, Glioma, Glioblastoma, Awake Craniotomy, and Thrombectomy.
Brigham And Womens Physicians Organization Inc
Omar Arnaout is a Neurosurgery provider in Boston, Massachusetts. Dr. Arnaout is rated as a Distinguished provider by MediFind in the treatment of Primitive Neuroectodermal Tumor (PNET). His top areas of expertise are Astrocytoma, Glioblastoma, Posterior Fossa Tumor, Awake Craniotomy, and Thrombectomy. Dr. Arnaout is currently accepting new patients.
Brigham And Womens Physicians Organization Inc
Elizabeth Claus is a Neurosurgery provider in Boston, Massachusetts. Dr. Claus is rated as a Distinguished provider by MediFind in the treatment of Primitive Neuroectodermal Tumor (PNET). Her top areas of expertise are Meningioma, Posterior Fossa Tumor, Primitive Neuroectodermal Tumor (PNET), and Metastatic Brain Tumor.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- AstrocytomaDr. Dunn isElite. Learn about Astrocytoma.
- GlioblastomaDr. Dunn isElite. Learn about Glioblastoma.
- GliomaDr. Dunn isElite. Learn about Glioma.
- Distinguished
- Brain TumorDr. Dunn isDistinguished. Learn about Brain Tumor.
- EpendymomaDr. Dunn isDistinguished. Learn about Ependymoma.
- Gliomatosis CerebriDr. Dunn isDistinguished. Learn about Gliomatosis Cerebri.
- MeningiomaDr. Dunn isDistinguished. Learn about Meningioma.
- Metastatic Brain TumorDr. Dunn isDistinguished. Learn about Metastatic Brain Tumor.
- OligodendrogliomaDr. Dunn isDistinguished. Learn about Oligodendroglioma.
- Advanced
- Atypical Teratoid Rhabdoid Tumor (ATRT)
- Awake CraniotomyDr. Dunn isAdvanced. Learn about Awake Craniotomy.
- Brain Stem CancerDr. Dunn isAdvanced. Learn about Brain Stem Cancer.
- Chronic Subdural HematomaDr. Dunn isAdvanced. Learn about Chronic Subdural Hematoma.
- Dysembryoplastic Neuroepithelial Tumors (DNET)
- Embryonal Tumor with Multilayered Rosettes
- Experienced
- ALK-Positive Non-Small Cell Lung Cancer
- ApoplexyDr. Dunn isExperienced. Learn about Apoplexy.
- Arachnoid CystsDr. Dunn isExperienced. Learn about Arachnoid Cysts.
- Brain AbscessDr. Dunn isExperienced. Learn about Brain Abscess.
- Cerebellum Agenesis HydrocephalyDr. Dunn isExperienced. Learn about Cerebellum Agenesis Hydrocephaly.
- Cerebral Ventricle CancerDr. Dunn isExperienced. Learn about Cerebral Ventricle Cancer.